| Commercial revenue | |
| Developmental revenue | |
| Total revenue | 64.39M |
| Cost of chemicals sold | 5.68M |
| Research and development | 10.97M |
| Selling, general and administrative | 7.69M |
| Patent costs | 4.06M |
| Royalty and license expense | 1.97M |
| Total operating expenses | 30.37M |
| Operating income (loss) | 34.03M |
| INTEREST INCOME | 661K |
| INTEREST EXPENSE | -8K |
| GAIN (LOSS) ON STOCK WARRANT LIABILITY | |
| INCOME (LOSS) BEFORE INCOME TAX EXPENSE | 32.85M |
| INCOME TAX (EXPENSE) BENEFIT | -11.05M |
| NET INCOME (LOSS) | 21.8M |
| Basic | 0.46 |
| Diluted | 0.46 |
| Basic | 46.93M |
| Diluted | 47.04M |